{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:56:03Z","timestamp":1791478563820,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G053122N"],"award-info":[{"award-number":["G053122N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["I008520N"],"award-info":[{"award-number":["I008520N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0C0222N"],"award-info":[{"award-number":["G0C0222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SH2Z24N"],"award-info":[{"award-number":["1SH2Z24N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["mx2525"],"award-info":[{"award-number":["mx2525"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117782","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T03:40:49Z","timestamp":1747798849000},"page":"117782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Investigating the structure-activity-relationship of diaryl ether-based paFabV inhibitors: A path to novel antibacterials"],"prefix":"10.1016","volume":"296","author":[{"given":"Radu-George","family":"Bulai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wout","family":"Van Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cremonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Van Olmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Wicik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Lescrinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Rozenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnout","family":"Voet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joleen","family":"Masschelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-2050","authenticated-orcid":false,"given":"Peter","family":"Verwilst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117782_bib2","series-title":"Final Report and Recommendations","article-title":"Tackling drug-resistant infections globally","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117782_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1615\/CritRevImmunol.v30.i1.60","article-title":"The global problem of antibiotic resistance","volume":"30","author":"Gootz","year":"2010","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117782_bib4","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp256","article-title":"The changing epidemiology of resistance","volume":"64","author":"Hawkey","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/antibiotics12040650","article-title":"Inhibitors of ATP synthase as new antibacterial candidates","volume":"12","author":"Mackieh","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117782_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ja.2013.86","article-title":"Antibiotics in the clinical pipeline in 2013","volume":"66","author":"Butler","year":"2013","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2025.117782_bib7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1021\/acsinfecdis.0c00044","article-title":"The antibacterial research and development pipeline needs urgent solutions","volume":"6","author":"Beyer","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117782_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-micro-041320-110408","article-title":"Mining fatty acid biosynthesis for new antimicrobials","volume":"76","author":"Radka","year":"2022","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117782_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cmdc.201300209","article-title":"Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents","volume":"8","author":"Wang","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117782_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mib.2011.07.029","article-title":"Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?","volume":"14","author":"Parsons","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117782_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.str.2012.03.013","article-title":"Staphylococcus aureus FabI: inhibition, substrate recognition, and potential implications for in vivo essentiality","volume":"20","author":"Schiebel","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.117782_bib12","doi-asserted-by":"crossref","first-page":"36261","DOI":"10.1074\/jbc.M113.512905","article-title":"Resistance to AFN-1252 arises from missense mutations in staphylococcus aureus enoyl-acyl carrier protein reductase (FabI)","volume":"288","author":"Yao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib13","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmc.2014.09.048","article-title":"Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/293662a0","article-title":"A diazaborine derivative inhibits lipopolysaccharide biosynthesis","volume":"293","author":"H\u00f6genauer","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117782_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.116.3006.129","article-title":"The chemical approach to the control of tuberculosis","volume":"116","author":"Fox","year":"1952","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117782_bib16","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1021\/bi00026a004","article-title":"Enzymic characterization of the target for isoniazid in Mycobacterium tuberculosis","volume":"34","author":"Quemard","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117782_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10937404.2017.1399306","article-title":"Triclosan exposure, transformation, and human health effects","volume":"20","author":"Weatherly","year":"2017","journal-title":"J. Toxicol. Environ. Health, Part A B"},{"key":"10.1016\/j.ejmech.2025.117782_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/18803","article-title":"Molecular basis of triclosan activity","volume":"398","author":"Levy","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117782_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/jm030182i","article-title":"Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure\u2212reactivity analysis of FabI inhibition by triclosan analogues","volume":"47","author":"Sivaraman","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib20","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1021\/jm301113w","article-title":"From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria","volume":"55","author":"Gerusz","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib21","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1021\/jm400637m","article-title":"Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum Enoyl-ACP-reductase (Pf FabI)","volume":"56","author":"Belluti","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/cmdc.200800047","article-title":"Design and synthesis of aryl ether inhibitors of the Bacillus anthracis Enoyl\u2010ACP reductase","volume":"3","author":"Tipparaju","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117782_bib23","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1128\/AAC.01248-10","article-title":"The MUT056399 inhibitor of FabI is a new antistaphylococcal compound","volume":"55","author":"Escaich","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib24","series-title":"Annu Rep Med Chem, First","first-page":"295","article-title":"Recent advances in the inhibition of bacterial fatty acid synthesis","author":"Gerusz","year":"2010"},{"key":"10.1016\/j.ejmech.2025.117782_bib25","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1016\/j.bmcl.2015.08.077","article-title":"Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent","volume":"25","author":"Kim","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkm236","article-title":"Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor","volume":"60","author":"Park","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ja.2007.11","article-title":"Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus","volume":"60","author":"Takahata","year":"2007","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.117782_bib28","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0960-894X(01)00404-8","article-title":"1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)","volume":"11","author":"Heerding","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib29","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1021\/jm0705354","article-title":"Phenylimidazole derivatives of 4-Pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK","volume":"50","author":"Kitagawa","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib30","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/AAC.01562-06","article-title":"In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea","volume":"51","author":"Yum","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib31","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1021\/jm020050+","article-title":"Discovery of aminopyridine-based inhibitors of bacterial Enoyl-ACP reductase (FabI)","volume":"45","author":"Miller","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/jm0204035","article-title":"Indole naphthyridinones as inhibitors of bacterial Enoyl-ACP reductases FabI and FabK","volume":"46","author":"Seefeld","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib33","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.01254-06","article-title":"In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis","volume":"51","author":"Karlowsky","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib34","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.00400-09","article-title":"AFN-1252, a FabI inhibitor, demonstrates a staphylococcus-specific spectrum of activity","volume":"53","author":"Karlowsky","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib35","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/acscentsci.2c00598","article-title":"An iterative approach guides discovery of the FabI inhibitor fabimycin, a late-stage antibiotic candidate with In Vivo efficacy against drug-resistant gram-negative infections","volume":"8","author":"Parker","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2025.117782_bib37","first-page":"30","article-title":"Microbe profile: pseudomonas aeruginosa: opportunistic pathogen and lab rat","volume":"166","author":"Diggle","year":"2020","journal-title":"Microbiology (United Kingdom)"},{"key":"10.1016\/j.ejmech.2025.117782_bib38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.01152-09","article-title":"Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase","volume":"54","author":"Zhu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117782_bib39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1074\/jbc.M708171200","article-title":"Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase","volume":"283","author":"Massengo-Tiass\u00e9","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib40","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3389\/fmicb.2016.01903","article-title":"Functional characterization of triclosan-resistant enoyl-acyl-carrier protein reductase (FabV) in Pseudomonas aeruginosa","volume":"7","author":"Huang","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117782_bib41","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1021\/acs.biochem.5b01301","article-title":"Selectivity of pyridone- and diphenyl ether-based inhibitors for the Yersinia pestis FabV Enoyl-ACP reductase","volume":"55","author":"Neckles","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117782_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.str.2011.07.019","article-title":"Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitors","volume":"20","author":"Hirschbeck","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.117782_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/ar700156e","article-title":"Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway","volume":"41","author":"Lu","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117782_bib44","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.bmcl.2008.04.038","article-title":"Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors","volume":"18","author":"am Ende","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib45","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/cmdc.201300429","article-title":"Time-dependent diaryl ether inhibitors of InhA: structure-Activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy","volume":"9","author":"Pan","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117782_bib46","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/jm801331y","article-title":"The pKBHX database: toward a better understanding of hydrogen-bond basicity for medicinal chemists","volume":"52","author":"Laurence","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib47","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1021\/acs.jmedchem.5b01946","article-title":"Hydrogen bond basicity prediction for medicinal chemistry design","volume":"59","author":"Kenny","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10822-016-0002-5","article-title":"The influence of hydrogen bonding on partition coefficients","volume":"31","author":"Borges","year":"2017","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2025.117782_bib49","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/bi5014358","article-title":"An ordered water channel in Staphylococcus aureus FabI: unraveling the mechanism of substrate recognition and reduction","volume":"54","author":"Schiebel","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117782_bib50","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/bi902001a","article-title":"Mechanism and inhibition of the FabV Enoyl-ACP reductase from Burkholderia mallei","volume":"49","author":"Lu","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117782_bib51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117782_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0610494104","article-title":"Ligand configurational entropy and protein binding","volume":"104","author":"Chang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117782_bib53","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acs.jcim.0c01146","article-title":"Ligand entropy is hard but should not be ignored","volume":"60","author":"Winkler","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.117782_bib54","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks (amino acid sequence\/alignment algorithms\/data base searching)","volume":"89","author":"Henikoff","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117782_bib55","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0040-4039(98)00503-6","article-title":"New N- and O-arylations with phenylboronic acids and cupric acetate","volume":"39","author":"Chan","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib56","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/S0040-4039(01)00510-X","article-title":"Copper-catalyzed general C-N and C-O bond cross-coupling with arylboronic acid","volume":"42","author":"Lam","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib57","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1081\/SCC-200026214","article-title":"Practical sulfonylation of amines with 4\u2010Hydroxybenzenesulfonyl chloride: in situ silylation\u2013desilylation","volume":"34","author":"Levin","year":"2004","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117782_bib58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.117782_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117782_bib60","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib61","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2025.117782_bib63","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building water models: a different approach","volume":"5","author":"Izadi","year":"2014","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117782_bib64","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2025.117782_bib65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib66","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/acs.jctc.0c00194","article-title":"Systematic parametrization of divalent metal ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models","volume":"16","author":"Li","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2025.117782_bib67","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B","article-title":"Improving efficiency of large time-scale molecular dynamics simulations of hydrogen-rich systems","volume":"20","author":"Feenstra","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117782_bib68","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/ct5010406","article-title":"Long-time-step molecular dynamics through hydrogen mass repartitioning","volume":"11","author":"Hopkins","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2025.117782_bib69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/math9111197","article-title":"Enriching elementary school mathematical learning with the steepest descent algorithm","volume":"9","author":"Araya","year":"2021","journal-title":"Mathematics"},{"key":"10.1016\/j.ejmech.2025.117782_bib70","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.cpc.2013.06.003","article-title":"A flexible algorithm for calculating pair interactions on SIMD architectures","volume":"184","author":"P\u00e1ll","year":"2013","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.ejmech.2025.117782_bib71","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.117782_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"P-LINCS: a parallel linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ejmech.2025.117782_bib73","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.117782_bib74","doi-asserted-by":"crossref","DOI":"10.1063\/5.0020514","article-title":"Pressure control using stochastic cell rescaling","volume":"153","author":"Bernetti","year":"2020","journal-title":"J. Chem. Phys."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:58:20Z","timestamp":1778623100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":72,"alternative-id":["S0223523425005471"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117782","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2023-5rgkp","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the structure-activity-relationship of diaryl ether-based paFabV inhibitors: A path to novel antibacterials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117782"}}